explore -WSS

explore

author：focus 2025-08-31 01:59:55 - browse：2

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： ARCH Venture Partners tops STAT's 2023 biotech VC rankings

WSS

Medicare to cover more brain scans for Alzheimer’s patients

Medicare has a new plan to address drug shortages

Obesity drug from Roche shows promise in early study

As H5N1 spreads in cows, experts warn against drinking raw milk

WuXi Biologics execs register to lobby as Congress comes for the company

Google and Epic fight stronger regulation of AI in health care

Wikipedia

explore

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Novo Nordisk testing Wegovy against alcohol

DIEP, the 'gold standard' of breast reconstruction, is under threat

Obesity drug from Roche shows promise in early study

After affirmative action ruling, medical educators look to 'holistic review'

The United States must get value

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden tests positive for Covid

Alkermes shareholders re

Startup Neumora takes a novel depression drug to Phase 3

entertainment

Custom gene therapy hints at new path for rare disease treatments

Key House panel plots a new health care package

Google and Epic fight stronger regulation of AI in health care

Abbott's new stent may help patients with peripheral artery disease

CVS is willing to dump 10% of its Medicare Advantage members

How Medicaid coverage policies for immigrants impact new moms

hotspot

entertainment

Wikipedia

hotspot